Individual Management Provider Workshop 
Physician's Weekly
JUNE 26, 2025
Created in consultation with emergency medicine professionals, the show aims to raise awareness and provide validation to frontline healthcare workers everywhere. The Warner Bros. The series dramatizes what surveys confirm: violence is not an exception in the ED—it is part of the environment.
My Green Doctor
APRIL 4, 2025
Heather Massey, Sustainability Programs Manager hmassey@mygreendoctor.org (469) 877-4608 Make the Pledge Today! If doctors, nurses, and practice managers highlight the connection between environmental factors and patient well-being, people listen—and they take action. from 2000 to 2018 among people over 65 years old. Contact us today!
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
JUNE 21, 2021
Sasinowski — On June 17, 2021, FDA gave notice of an upcoming public workshop focused on clinical trial designs for progressive multifocal leukoencephalopathy (PML). PML is a rare disease that occurs when the JC virus (JCV), generally thought to lie dormant in the adult population, takes advantage of immunocompromised individuals.
LEAD Physician
SEPTEMBER 19, 2022
A leadership program is designed to help future leaders improve their understanding of leadership, communication, and management skills. Leadership programs can be tailored to specific roles within an organization or for more general purposes, such as leadership skills for managers or leaders of different levels.
LEAD Physician
SEPTEMBER 26, 2022
Physicians must be leaders in their field to provide excellent patient care, manage a large team and coordinate between departments, and support their patient's overall health with information about prevention and maintenance. Physicians must constantly shift gears from one situation to another.
FDA Law Blog
JULY 17, 2024
Importantly, the Hub is intended to establish a new model within FDA, which leverages cross-Agency expertise in providing guidance and conducting reviews for products for rare disease populations. those reviewed by the CDER Division of Rare Diseases and Medical Genetics).
FDA Law Blog
SEPTEMBER 20, 2021
FDA will discuss the goals letter and field public comments, on September 28, 2021 (announcement here ), as well as a separate workshop on meetings management practices, which is to be held by July 30, 2024. The Agency will hold as many as three public workshops during PDUFA VII related to rare disease endpoint development.
Expert insights. Personalized for you.
59 
Let's personalize your content